Although reported as second quarter V-Go revenues for Mannkind, according to MNKD, the $2.1 M in V-Go revenues only included June V-Go revenues.
Zealand Pharma, who owned V-Go previously, reported V-Go April and May revenues as theirs. When you multiply $2.1 M by 12, you get $25.2 M (if annualized), and MNKD feels that V-Go has been neglected promotionally since 2021. A tidbit from the second quarter cc. JMHO.